Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Simon, Ekman"'
Autor:
Asaf Dan, Ozan Aricak, Konstantinos Rounis, M. Angeles Montero-Fernandez, Ricardo Guijarro, Simon Ekman, Cristian Ortiz-Villalón, Luigi De Petris
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionProgrammed death ligand – 1 (PD-L1) expression is a well-established predictive biomarker for immunotherapy in non-small cell lung cancer (NSCLC). Programmed death – 1 (PD-1) serves as the target protein to PD-L1 and their interaction
Externí odkaz:
https://doaj.org/article/6bc2bad02c314212b6aa290293416a85
Autor:
Simon Ekman, Zsolt Cselényi, Andrea Varrone, Aurelija Jucaite, Heather Martin, Magnus Schou, Peter Johnström, Gianluca Laus, Rolf Lewensohn, Andrew P. Brown, Jasper van derAart, Karthick Vishwanathan, Lars Farde
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 6, Pp 955-965 (2023)
Abstract Brain metastases (BMs) are associated with poor prognosis in epidermal growth factor receptor mutation‐positive (EGFRm) non‐small cell lung cancer (NSCLC). Osimertinib is a third‐generation, irreversible, EGFR‐tyrosine kinase inhibit
Externí odkaz:
https://doaj.org/article/fe8e055f9652498db9a233ac1fdc48e7
Autor:
Kai Guo, Zhiqiang Ma, Yujiao Zhang, Lu Han, Changjian Shao, Yingtong Feng, Fei Gao, Shouyin Di, Zhipei Zhang, Jiao Zhang, Fabrizio Tabbò, Simon Ekman, Kenichi Suda, Federico Cappuzzo, Jing Han, Xiaofei Li, Xiaolong Yan
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-19 (2022)
Abstract Background Histone deacetylases (HDACs) play crucial roles in cancers, but the role and mechanism of HDAC7 in NSCLC have not been fully understood. Methods A total of 319 patients with non-small cell lung cancer (NSCLC) who underwent surgery
Externí odkaz:
https://doaj.org/article/abc69dd4f2614b9a80ba91fd95d83a97
Autor:
Elinor Nemlander, Andreas Rosenblad, Eliya Abedi, Simon Ekman, Jan Hasselström, Lars E Eriksson, Axel C Carlsson
Publikováno v:
PLoS ONE, Vol 18, Iss 12, p e0295780 (2023)
[This corrects the article DOI: 10.1371/journal.pone.0276703.].
Externí odkaz:
https://doaj.org/article/a12b7476d9d64a319d917d08304fa6ca
Autor:
Dimitrios Makrakis, Konstantinos Rounis, Alexandros-Pantelis Tsigkas, Alexandra Georgiou, Nikolaos Galanakis, George Tsakonas, Simon Ekman, Chara Papadaki, Alexia Monastirioti, Meropi Kontogianni, Ioannis Gioulbasanis, I Mavroudis, Sofia Agelaki
Publikováno v:
PLoS ONE, Vol 18, Iss 11, p e0294384 (2023)
[This corrects the article DOI: 10.1371/journal.pone.0277708.].
Externí odkaz:
https://doaj.org/article/24df822d0a864f79b9de18478b0ba9eb
Autor:
Dimitrios Makrakis, Konstantinos Rounis, Alexandros-Pantelis Tsigkas, Alexandra Georgiou, Nikolaos Galanakis, George Tsakonas, Simon Ekman, Chara Papadaki, Alexia Monastirioti, Meropi Kontogianni, Ioannis Gioulbasanis, Dimitris Mavroudis, Sofia Agelaki
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0277708 (2023)
Obesity and sarcopenia have been reported to affect outcomes in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs). We analyzed prospective data from 52 patients with non-oncogene driven metastatic NSCLC
Externí odkaz:
https://doaj.org/article/b70a2b3772264cf5ae57cb9b6377d397
Autor:
Bo Franzén, Kristina Viktorsson, Caroline Kamali, Eva Darai‐Ramqvist, Vitali Grozman, Vasiliki Arapi, Petra Hååg, Vitaliy O. Kaminskyy, Per Hydbring, Lena Kanter, Sven Nyrén, Simon Ekman, Luigi De Petris, Rolf Lewensohn
Publikováno v:
Molecular Oncology, Vol 15, Iss 11, Pp 2941-2957 (2021)
Biomarker signatures identified through minimally invasive procedures already at diagnosis of non‐small‐cell lung cancer (NSCLC) could help to guide treatment with immune checkpoint inhibitors (ICI). Here, we performed multiplex profiling of immu
Externí odkaz:
https://doaj.org/article/9e0829fc3242405c83f4c08c0562067b
Autor:
Mahsan Banijamali, Pontus Höjer, Abel Nagy, Petra Hååg, Elizabeth Paz Gomero, Christiane Stiller, Vitaliy O. Kaminskyy, Simon Ekman, Rolf Lewensohn, Amelie Eriksson Karlström, Kristina Viktorsson, Afshin Ahmadian
Publikováno v:
Journal of Extracellular Vesicles, Vol 11, Iss 11, Pp n/a-n/a (2022)
Abstract Small extracellular vesicles (sEVs) have in recent years evolved as a source of biomarkers for disease diagnosis and therapeutic follow up. sEV samples derived from multicellular organisms exhibit a high heterogeneous repertoire of vesicles
Externí odkaz:
https://doaj.org/article/0fdbc9628da14fb7a1118ee97c8cdc0e
Autor:
Simon Ekman, Glaydson Simoes dos Reis, Ewen Laisné, Julie Thivet, Alejandro Grimm, Eder Claudio Lima, Mu. Naushad, Guilherme Luiz Dotto
Publikováno v:
Nanomaterials, Vol 13, Iss 14, p 2045 (2023)
In this work, nitrogen-doped porous biochars were synthesized from spruce bark waste using a facile single-step synthesis process, with H3PO4 as the chemical activator. The effect of nitrogen doping on the carbon material’s physicochemical properti
Externí odkaz:
https://doaj.org/article/37345c39a41e4bdc90931bacfb6b964b
Autor:
Elinor Nemlander, Andreas Rosenblad, Eliya Abedi, Simon Ekman, Jan Hasselström, Lars E Eriksson, Axel C Carlsson
Publikováno v:
PLoS ONE, Vol 17, Iss 10, p e0276703 (2022)
PurposeThe aim of the present study was to investigate the predictive ability for lung cancer of symptoms reported in an adaptive e-questionnaire, separately for never smokers, former smokers, and current smokers.Patients and methodsConsecutive patie
Externí odkaz:
https://doaj.org/article/9654b4dac27441989483bd9b9f97bd61